Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity

BACKGROUND: Biomarkers for predicting late normal tissue toxicity to radiotherapy are necessary to personalize treatments and to optimize clinical benefit. Many radiogenomic studies have been published on this topic. Conversely, proteomics approaches are not much developed, despite their advantages....

Descripción completa

Detalles Bibliográficos
Autores principales: Lacombe, Jérôme, Brengues, Muriel, Mangé, Alain, Bourgier, Céline, Gourgou, Sophie, Pèlegrin, André, Ozsahin, Mahmut, Solassol, Jérôme, Azria, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688300/
https://www.ncbi.nlm.nih.gov/pubmed/31399108
http://dx.doi.org/10.1186/s13014-019-1351-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688300/
https://www.ncbi.nlm.nih.gov/pubmed/31399108
http://dx.doi.org/10.1186/s13014-019-1351-8

Ejemplares similares